Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Pallansch

Showing results (21-30 of 160) with videos related to

Pageof 16
Sort By:
Vaccine|April 25, 2017
Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization scheduleAbhijeet Anand, Natalie A Molodecky, Mark A Pallansch, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 18, 2010
Parechovirus typing in clinical specimens by nested or semi-nested PCR coupled with sequencingW Allan Nix, Kaija Maher, Mark A Pallansch, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 15, 2003
Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencingM Steven Oberste, William A Nix, Kaija Maher, et al.
Food and Environmental Virology|July 9, 2017
Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance SystemsRadboud J Duintjer Tebbens, Marita Zimmermann, Mark A Pallansch, et al.
The Journal of Infectious Diseases|April 22, 2021
Updated Characterization of Poliovirus Transmission in Pakistan and Afghanistan and the Impacts of Different Outbreak Response Vaccine OptionsDominika A Kalkowska, Mark A Pallansch, Stephen L Cochi, et al.
Open Forum Infectious Diseases|July 23, 2021
Modeling Poliovirus Surveillance and Immunization Campaign Quality Monitoring Costs for Pakistan and Afghanistan for 2019-2023Dominika A Kalkowska, Mark A Pallansch, Stephen L Cochi, et al.
The Journal of General Virology|February 13, 2001
Molecular identification of new picornaviruses and characterization of a proposed enterovirus 73 serotypeM Steven Oberste, David Schnurr, Kaija Maher, et al.
The Journal of Infectious Diseases|August 26, 2017
The Global Polio Laboratory Network as a Platform for the Viral Vaccine-Preventable and Emerging Diseases Laboratory NetworksOusmane M Diop, Olen M Kew, Esther M de Gourville, et al.
Vaccine|May 1, 2010
Optimal vaccine stockpile design for an eradicated disease: application to polioRadboud J Duintjer Tebbens, Mark A Pallansch, James P Alexander, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|October 9, 2018
Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Pakistan and AfghanistanDominika A Kalkowska, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Pageof 16

Showing results (21-30 of 160) with videos related to

Sort By:
Pageof 16
Vaccine|April 25, 2017
Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization scheduleAbhijeet Anand, Natalie A Molodecky, Mark A Pallansch, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 18, 2010
Parechovirus typing in clinical specimens by nested or semi-nested PCR coupled with sequencingW Allan Nix, Kaija Maher, Mark A Pallansch, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 15, 2003
Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencingM Steven Oberste, William A Nix, Kaija Maher, et al.
Food and Environmental Virology|July 9, 2017
Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance SystemsRadboud J Duintjer Tebbens, Marita Zimmermann, Mark A Pallansch, et al.
The Journal of Infectious Diseases|April 22, 2021
Updated Characterization of Poliovirus Transmission in Pakistan and Afghanistan and the Impacts of Different Outbreak Response Vaccine OptionsDominika A Kalkowska, Mark A Pallansch, Stephen L Cochi, et al.
Open Forum Infectious Diseases|July 23, 2021
Modeling Poliovirus Surveillance and Immunization Campaign Quality Monitoring Costs for Pakistan and Afghanistan for 2019-2023Dominika A Kalkowska, Mark A Pallansch, Stephen L Cochi, et al.
The Journal of General Virology|February 13, 2001
Molecular identification of new picornaviruses and characterization of a proposed enterovirus 73 serotypeM Steven Oberste, David Schnurr, Kaija Maher, et al.
The Journal of Infectious Diseases|August 26, 2017
The Global Polio Laboratory Network as a Platform for the Viral Vaccine-Preventable and Emerging Diseases Laboratory NetworksOusmane M Diop, Olen M Kew, Esther M de Gourville, et al.
Vaccine|May 1, 2010
Optimal vaccine stockpile design for an eradicated disease: application to polioRadboud J Duintjer Tebbens, Mark A Pallansch, James P Alexander, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|October 9, 2018
Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Pakistan and AfghanistanDominika A Kalkowska, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Pageof 16